4 July 2016; 
Company Announcement Pro Medicus Signs Mayo Clinic – Acrobat pdf 123k
Key Points
- PME signs 6 year deal with Mayo Clinic in the US
- Visage 7 to be implemented enterprise-wide throughout Mayo Clinic’s Radiology departments
- Estimated value to PME in excess of AUD $18 million
- Transaction-based model with potential upside
- Third major US deal in 4 months
- Recent deals reposition PME in US market
Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned US subsidiary, Visage Imaging, Inc., has signed an AUD $18 million, six-year contract with Mayo Clinic.
The contract, based on a transaction licensing model, will see Pro Medicus’ Visage 7 technology implemented across Mayo Clinic’s Radiology practices.
Project planning has begun with the first sites scheduled to move into production in the second quarter of FY2017 with the remaining sites rolling out over an 18 month period with project completion set for the fourth quarter of FY2018.
“This is a very significant contract for us and further validates our belief that Visage 7 is uniquely positioned to cater for the needs of the most sophisticated and demanding clinical environments,” said Dr Sam Hupert, Pro Medicus CEO. “It has the speed and functionality to meet the requirements of a large and diverse group of high-end clinical users as well as the scalability to handle the huge data volumes that a medical enterprise of this size generates”.
Dr Hupert continued, “This is the third major deal we have signed in the past few months following our recent Mercy and FMOLHS announcements, and further cements our growing footprint in the North American market. With this deal we have reached another major milestone in terms of market acceptance and we look to build on this as a basis for continued growth in both North American and other global markets.”
